Lupin shares up 0.56% as Sensex falls

The stock opened at Rs 1765.0 and has touched an intraday high and low of Rs 1785.0 and Rs 1755.5 during the session so far. The scrip quoted a price-to-earnings (PE) ratio of 42.07, earnings per share (EPS) of Rs 42.01 and price to book value (PB) of 5.16, while the return on equity (ROE) stood at Rs 13.39.

Promoter/ FII Holding
The promoters held 47.01 per cent stake in the company as of July 05, while FII and MF ownerships stood at 18.29 per cent and 16.82 per cent, respectively.

Key Financials
With a market capitalisation of Rs 80525.3 crore, the company operates in the Pharma - Indian industry. For the quarter ended 31-Mar-2024, the company reported consolidated sales of Rs 4990.04 crore, down 4.53 per cent from the previous quarter?s Rs 5226.78 crore and down 11.7 per cent from the same quarter a year ago. The company reported net profit of Rs 359.43 crore for the latest quarter, up 52.33 per cent from the corresponding quarter last year.

Technical Indicators
The relative strength index (RSI) of the stock stands at 74.78. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.